作者对致函编辑的回复。

IF 2.2 4区医学 Q3 PHARMACOLOGY & PHARMACY

Journal of Pharmacokinetics and Pharmacodynamics Pub Date : 2024-08-01 Epub Date: 2024-05-27 DOI:10.1007/s10928-024-09927-6

Euibeom Shin, Yifan Yu, Robert R Bies, Murali Ramanathan

引用次数: 0

摘要

作者对 Hinpetch Daungsupawong 和 Viroj Wiwanitkit 致编辑信的回复。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Authors' response to letter to editor.

Authors' Response to Letter to Editor from Hinpetch Daungsupawong and Viroj Wiwanitkit.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Pharmacokinetics and Pharmacodynamics 医学-药学

CiteScore

4.90

自引率

4.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Broadly speaking, the Journal of Pharmacokinetics and Pharmacodynamics covers the area of pharmacometrics. The journal is devoted to illustrating the importance of pharmacokinetics, pharmacodynamics, and pharmacometrics in drug development, clinical care, and the understanding of drug action. The journal publishes on a variety of topics related to pharmacometrics, including, but not limited to, clinical, experimental, and theoretical papers examining the kinetics of drug disposition and effects of drug action in humans, animals, in vitro, or in silico; modeling and simulation methodology, including optimal design; precision medicine; systems pharmacology; and mathematical pharmacology (including computational biology, bioengineering, and biophysics related to pharmacology, pharmacokinetics, orpharmacodynamics). Clinical papers that include population pharmacokinetic-pharmacodynamic relationships are welcome. The journal actively invites and promotes up-and-coming areas of pharmacometric research, such as real-world evidence, quality of life analyses, and artificial intelligence. The Journal of Pharmacokinetics and Pharmacodynamics is an official journal of the International Society of Pharmacometrics.